XENE Xenon Pharmaceuticals Inc

held by 1 manager in Q2 2026

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.33%	6 mo	—	$14M	238,600

Search